<DOC>
	<DOCNO>NCT00986102</DOCNO>
	<brief_summary>The purpose study understand utilization pattern doripenem Asia Pacific , include profile patient treat carbapenems .</brief_summary>
	<brief_title>PROUD Study : A Prospective Study Usage Patterns Doripenem Asia Pacific Region</brief_title>
	<detailed_description>This Phase 4 , prospective , open-label , non-comparative , multicenter study characterize usage doripenem select hospital Asia Pacific region . Doripenem belong carbapenem class broad-spectrum antibiotic give treat patient serious infection , pneumonia complicate intra-abdominal infection . Physicians select hospital hospital unit refer potential patient study team . Patients include men woman 18 year age old , hospitalize either Intensive Care Unit ( ICU ) ward , diagnosis pneumonia , complicate intra-abdominal infection complicate urinary tract infection . The study 3 phase : pretreatment phase 1-day screening/baseline visit , treatment phase 5 14 day , post-treatment phase consist end-of-treatment ( EOT ) /early withdrawal visit conduct within 24 hour last dose antimicrobial therapy , test cure ( TOC ) visit 7 14 day EOT , Day 28 visit , post-discharge visit 28 day discharge hospital . Usage Doripenem term approve indication , mode usage , duration antibiotic therapy , patient characteristic assess . Safety assess monitor adverse event , serial physical examination , collection conventional laboratory data ( chemistry panel , complete blood count differential ) . Being prospective study , patient data gather patient enrol , start present condition follow duration study . The study compare Doripenem antibiotic primary endpoint . One vial ( 500mg ) doripenem intravenously ( injection ) every 8 hour 5 14 day</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<criteria>Patients hospitalize either ICU ward , diagnosis pneumonia , complicate abdominal infection , complicate urinary tract infection use protocoldefined Guidelines Diagnosis Pregnant lactate female Allergies Doripenem derivative Infected bacteria resistant Doripenem Taking probenecid Severe allergies antibiotic like penicillin , cephalosporin , carbapenems Severe kidney disease , unstable disease state assess unlikely survive study follow period Signs severe sepsis treatment failure carbapenems , receive carbapenem within 2 week first dose study drug , condition , opinion investigator , would compromise wellbeing patient study prevent patient meeting perform study requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Carbapenem</keyword>
	<keyword>Doripenem</keyword>
	<keyword>Doribax</keyword>
	<keyword>Nosocomial pneumonia , Intra-abdominal infection</keyword>
	<keyword>Urinary tract infection</keyword>
</DOC>